Provided by Tiger Fintech (Singapore) Pte. Ltd.

BeiGene

184.71
+0.0000
Volume:- -
Turnover:61.43M
Market Cap:19.67B
PE:-22.56
High:184.71
Open:184.71
Low:184.71
Close:184.71
Loading ...

BeiGene Grants New Stock Options and RSUs

TIPRANKS
·
04 Oct 2024

Stock Track | BeiGene Rallies Nearly 10% Pre-Market on SEC Filing Compliance Update

Stock Track
·
30 Sep 2024

BeiGene Ltd. Announces SEC Filing Compliance

TIPRANKS
·
30 Sep 2024

Stock Track | BeiGene Shares Soar on FDA Panel's Positive View of Cancer Drug Tevimbra

Stock Track
·
29 Sep 2024

Stock Track | BeiGene Soars on FDA Panel's Favorable View of Cancer Drug Tevimbra

Stock Track
·
27 Sep 2024

BeiGene Shares Climb Pre-Bell After FDA Gives Favorable Opinion on Class of Cancer Treatments

MT Newswires Live
·
27 Sep 2024

BeiGene Announces Board and Committee Structure

TIPRANKS
·
27 Sep 2024

BeiGene says FDA’s ODAC sees favorable benefit-risk profile of PD-1 inhibitors

TIPRANKS
·
27 Sep 2024

Atour Lifestyle, Nvidia, Beigene Among 9 New Names On IBD Hot Lists

Blockhead
·
27 Sep 2024

BRIEF-Beigene - Changed Size Of Board From 11 To 12 Persons

Reuters
·
26 Sep 2024

BRIEF-Global Oncology Innovator Beigene Appoints Shalini Sharp To Board Of Directors

Reuters
·
26 Sep 2024

FDA Casts Doubt On Use Of Merck, Bristol Myers' PD-1 Cancer Drugs For Certain Type Of Gastric Cancer Patients

Benzinga
·
26 Sep 2024

BeiGene Announces EGM Record Date for Domicile Shift

TIPRANKS
·
20 Sep 2024

JMP Securities Initiates BeiGene at Outperform With $288 Price Target

MT Newswires Live
·
18 Sep 2024

BeiGene Initiated at Market Outperform by JMP Securities

Dow Jones
·
18 Sep 2024

Reni Benjamin Endorses BeiGene with a Buy Rating Amidst Strong Financial Outlook and Market Penetration

TIPRANKS
·
18 Sep 2024